1991
DOI: 10.1016/0091-2182(91)90022-h
|View full text |Cite
|
Sign up to set email alerts
|

Delay in diagnosis of breast cancer A professional liability risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1992
1992
2010
2010

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…The number of lawsuits related to failure to diagnose breast cancer have been on the rise (100). Although it is important that clinical practice be driven by professional standards and not by fear of lawsuits, one must recognize that litigation proceedings often are related either to a practitioner's not having followed the current standards of practice or to the legitimacy of the standards being questioned (110).…”
Section: Caveats and Conclusionmentioning
confidence: 99%
See 1 more Smart Citation
“…The number of lawsuits related to failure to diagnose breast cancer have been on the rise (100). Although it is important that clinical practice be driven by professional standards and not by fear of lawsuits, one must recognize that litigation proceedings often are related either to a practitioner's not having followed the current standards of practice or to the legitimacy of the standards being questioned (110).…”
Section: Caveats and Conclusionmentioning
confidence: 99%
“…False‐positive readings can lead to unnecessary surgery and psychological trauma. False‐negative interpretations run the risk of undiagnosed carcinoma and subsequent morbidity and mortality, as well as potential legal complications (45, b94, 100, 101). The inability of the medical world to oversee quality assurance of MAM screening has led to a lack of confidence in the general public regarding this testing and helped to bring about the congressional passage of the Mammography Quality Standards Act of 1992, which implements Food and Drug Administration regulation of the MAM screening industry (99).…”
Section: Breast Cancer In Older Womenmentioning
confidence: 99%
“…Asking the patient to contact the office for results does not excuse the clinician from responsibility for tracking results. As Sarah Cohn wrote in the Journal of Nurse‐Midwifery : “It is not possible to defend a case in which a mammogram or other laboratory report that has findings requiring follow‐up gets overlooked and filed.” 2 …”
Section: Tracking Systemsmentioning
confidence: 99%
“…As Sarah Cohn wrote in the Journal of Nurse-Midwifery: "It is not possible to defend a case in which a mammogram or other laboratory report that has findings requiring follow-up gets overlooked and filed." 2 In addition to tracking clinical results and referrals, providers need to monitor whether a woman returns when visits are scheduled for problem management. One review of legal risks associated with breast cancer diagnoses noted that physicians do not always pursue missed appointments, even if there is a plan to follow the patient at specific intervals.…”
Section: Tracking Systemsmentioning
confidence: 99%